UPDATE: Bank of America Downgrades Vitamin Shoppe to Underperform on Decelerating Trends
In a report published Wednesday, Bank of America analyst Denise Chai downgraded the rating on Vitamin Shoppe (NYSE: VSI) from Neutral to Underperform, and lowered the price target from $55.00 to $40.00.
In the report, Chai noted, “We downgraded VSI from Buy to Neutral in February on these concerns, which are now more elevated. As such, we do not believe a premium valuation is warranted. Given growing concerns, we are lowering our estimates as follows: 2013 is now $2.32 on 3.5% comps ($2.37 on a 6% comp prior); 2014 is $2.58 ($2.68 prior); and 2015 is $2.85 ($2.99 prior). We are lowering our PO to $40 (from $55), based on 17x our 2013E EPS (23x prior). We believe a multiple more inline with our Hardlines universe is justified, and we do not expect trading multiples to rerate until comps reaccelerate.”
Vitamin Shoppe closed on Tuesday at $45.24.
Latest Ratings for VSI
|Jan 2017||Goldman Sachs||Downgrades||Neutral||Sell|
|Jan 2017||Morgan Stanley||Downgrades||Equal-Weight||Underweight|
|Nov 2016||Morgan Stanley||Downgrades||Overweight||Equal-Weight|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.